Annual Net Margin
-37.96%
+33.89%+47.17%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual net profit margin is -37.96%, with the most recent change of +33.89% (+47.17%) on December 31, 2023.
- During the last 3 years, FOLD annual net margin has risen by +68.16% (+64.23%).
- FOLD annual net margin is now -272.16% below its all-time high of -10.20%, reached on December 31, 2009.
Performance
FOLD Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-4.75%
+7.64%+61.66%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly net profit margin is -4.75%, with the most recent change of +7.64% (+61.66%) on September 30, 2024.
- Over the past year, FOLD quarterly net margin has increased by +16.10% (+77.22%).
- FOLD quarterly net margin is now -107.13% below its all-time high of 66.61%, reached on December 31, 2009.
Performance
FOLD Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
FOLD Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.2% | +77.2% |
| 3 y3 years | +64.2% | +77.2% |
| 5 y5 years | +90.1% | +77.2% |
FOLD Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.7% | at high | +95.6% |
| 5 y | 5-year | at high | +80.6% | at high | +97.1% |
| alltime | all time | -272.2% | +99.8% | -107.1% | +100.0% |
Amicus Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -4.75%(-61.7%) |
| Jun 2024 | - | -12.39%(-71.8%) |
| Mar 2024 | - | -43.86%(+49.1%) |
| Dec 2023 | -37.96%(-47.2%) | -29.41%(+41.1%) |
| Sep 2023 | - | -20.85%(-54.4%) |
| Jun 2023 | - | -45.75%(-25.4%) |
| Mar 2023 | - | -61.36%(-3.2%) |
| Dec 2022 | -71.85%(-12.4%) | -63.41%(+55.6%) |
| Sep 2022 | - | -40.75%(-47.1%) |
| Jun 2022 | - | -76.99%(-28.9%) |
| Mar 2022 | - | -108.31%(+6.8%) |
| Dec 2021 | -81.98%(-22.7%) | -101.37%(+60.3%) |
| Sep 2021 | - | -63.23%(-4.4%) |
| Jun 2021 | - | -66.17%(-33.1%) |
| Mar 2021 | - | -98.89%(-2.3%) |
| Dec 2020 | -106.12%(-45.7%) | -101.18%(+6.6%) |
| Sep 2020 | - | -94.92%(+12.7%) |
| Jun 2020 | - | -84.19%(-42.7%) |
| Mar 2020 | - | -146.96%(-9.4%) |
| Dec 2019 | -195.56%(-48.9%) | -162.28%(+28.0%) |
| Sep 2019 | - | -126.74%(-33.9%) |
| Jun 2019 | - | -191.60%(-45.8%) |
| Mar 2019 | - | -353.34%(+47.7%) |
| Dec 2018 | -382.48%(-50.3%) | -239.19%(-69.0%) |
| Sep 2018 | - | -772.79%(+166.3%) |
| Jun 2018 | - | -290.17%(-2.9%) |
| Mar 2018 | - | -298.97%(-36.4%) |
| Dec 2017 | -769.03% | -469.88%(-54.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | -1026.91%(+52.7%) |
| Jun 2017 | - | -672.48%(-49.0%) |
| Mar 2017 | - | -1319.07%(-36.3%) |
| Dec 2016 | -4034.73%(-28.4%) | -2071.60%(-5.6%) |
| Sep 2016 | - | -2193.42%(-62.5%) |
| Dec 2014 | -5631.21%(-65.7%) | - |
| Sep 2014 | - | -5852.90%(+90.2%) |
| Jun 2014 | - | -3076.63%(-12.0%) |
| Mar 2014 | - | -3496.27%(-7.4%) |
| Dec 2013 | -16.43 K%(+6099.6%) | -3776.85%(-89.9%) |
| Sep 2013 | - | -37.41 K%(>+9900.0%) |
| Dec 2012 | -264.98%(+27.9%) | - |
| Jun 2012 | - | -87.83%(-48.0%) |
| Mar 2012 | - | -168.99%(+9.8%) |
| Dec 2011 | -207.20%(-96.5%) | -153.85%(-8.6%) |
| Sep 2011 | - | -168.32%(-46.2%) |
| Jun 2011 | - | -312.90%(+39.8%) |
| Mar 2011 | - | -223.77%(-86.3%) |
| Dec 2010 | -5958.35%(>+9900.0%) | -1636.44%(-2556.7%) |
| Dec 2009 | -10.20%(-96.1%) | 66.61%(-124.4%) |
| Sep 2009 | - | -273.34%(+7.6%) |
| Jun 2009 | - | -254.11%(-6.2%) |
| Mar 2009 | - | -270.78%(-16.9%) |
| Dec 2008 | -262.95%(-88.6%) | -325.66%(+45.4%) |
| Sep 2008 | - | -223.93%(-8.3%) |
| Jun 2008 | - | -244.13%(-0.2%) |
| Mar 2008 | - | -244.65% |
| Dec 2007 | -2307.57% | - |
FAQ
- What is Amicus Therapeutics annual net profit margin?
- What is the all time high annual net margin for Amicus Therapeutics?
- What is Amicus Therapeutics annual net margin year-on-year change?
- What is Amicus Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly net margin year-on-year change?
What is Amicus Therapeutics annual net profit margin?
The current annual net margin of FOLD is -37.96%
What is the all time high annual net margin for Amicus Therapeutics?
Amicus Therapeutics all-time high annual net profit margin is -10.20%
What is Amicus Therapeutics annual net margin year-on-year change?
Over the past year, FOLD annual net profit margin has changed by +33.89% (+47.17%)
What is Amicus Therapeutics quarterly net profit margin?
The current quarterly net margin of FOLD is -4.75%
What is the all time high quarterly net margin for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly net profit margin is 66.61%
What is Amicus Therapeutics quarterly net margin year-on-year change?
Over the past year, FOLD quarterly net profit margin has changed by +16.10% (+77.22%)